Investigational Drug Details
| Drug ID: | D230 |
| Drug Name: | MK-4074 |
| Synonyms: | -- |
| Type: | Chemical drug |
| DrugBank ID: | -- |
| DrugBank Description: | -- |
| PubChem ID: | 24964679 |
| CasNo: | 1039758-22-9 |
| Repositioning for NAFLD: | Yes |
| SMILES: | O=C1CC2(Oc3c1cc(cc3)c1cc(C(=O)O)cnc1)CCN(CC2)C(=O)c1cc2n(cc(c2c(c1)OC)C)C1CC1 |
| Structure: |
|
| InChiKey: | WDBNGXLHMZSUEI-UHFFFAOYSA-N |
| Molecular Weight: | 565.626 |
| DrugBank Targets: | -- |
| DrugBank MoA: | -- |
| DrugBank Pharmacology: | -- |
| DrugBank Indication: | -- |
| Targets: | ACC inhibitor |
| Therapeutic Category: | -- |
| Clinical Trial Progress: | Phase 1 completed (NCT01431521) |
| Latest Progress: | Under clinical trials |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
|---|---|---|---|---|---|---|---|
| L0099 | NCT01431521 | Phase 1 | Completed | Has Results | October 26, 2011 | September 10, 2018 | Details |
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|